In a multinational double-blind trial (EORTC 18071 [NCT00636168]), patients with stage III melanoma, who had complete resection, were randomly assigned (1:1) to receive either ipilimumab or placebo.[30][Level of evidence B1] Exclusion criteria comprised patients with lymph node metastasis larger than 1 mm, in-transit metastasis, resection occurring more than 12 weeks before randomization, autoimmune disease, previous or concurrent immunosuppressive therapy, previous systemic therapy for melanoma, and an ECOG PS score higher than 1
Contact your healthcare provider if you experience: Hot flashes accompanied by chest pain, palpitations, or irregular heartbeat Severe or persistent flushing with associated shortness of breath or dizziness Hot flashes that significantly interfere with daily activities or sleep quality New or worsening symptoms despite lifestyle modifications Severe, persistent abdominal pain (especially radiating to the back) with or without vomiting Yellowing of skin/eyes (jaundice), pale stools, or dark urine Signs of allergic reaction including facial/lip swelling, rash, hives, or difficulty breathing Signs of thyroid dysfunction including tremor, anxiety, or changes in bowel habits Concurrent symptoms such as excessive sweating, fever, or night sweats If you're taking tirzepatide with insulin or sulfonylureas, check your blood glucose during episodes that resemble hot flashes, as hypoglycemia can cause similar symptoms
Always check the packaging for specific storage instructions
Antioxidant status and lipid peroxidation in colorectal cancer
Immediately discontinue use and contact your healthcare professional if you experience any adverse reaction to this product
Comment: Numerous commenters were in favor of establishing a G-code as they emphasized intraoperative intercostal nerve cryoablation being a clinically valuable adjunct therapy that significantly improves patient outcomes
